Sign in
Taking people in South AfricaNo phase

Smartphone Cough Recordings to Help Screen for Tuberculosis

Tests whether a phone app can sort cough sounds to flag possible tuberculosis.

Key facts

Who runs it
University of Stellenbosch
Where
Cape Town, South AfricaSee the siteAlso in 1 other country, 1 site
Trial code
Registry title
Cough Audio Classification as a TB Triage Test
Status
Recruiting
People taking part
1,751 people, planned
Started
19 Apr 2022
Expected to end
30 Dec 2027
Type of study
Observational, 2 groups
Treatments tested
  • Cough sounds
Record updated
6 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 12 or older who have had a cough for at least two weeks. It tests a smartphone app that listens to coughs to help find tuberculosis (TB).

Age
12 years or older
Sex
All sexes can join.
Disease stage
A prolonged cough lasting at least two weeks.
Earlier treatment
No treatment for TB in the 60 days before joining.
Biomarker or test result
Known HIV status, or willing to have standard HIV testing and counseling.

Main reasons for not taking part

  • Refuses informed consent
  • Treated for TB in the 60 days before joining
  • Cannot give a sputum sample for lab testing
  • Coughs up blood or has a bloody cough with any forced cough for the audio recordings

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • participant must be at least 12 years old
  • participant must have a prolonged cough (for at least two weeks)
  • participant must provide informed consent
  • participant shall have a known HIV status or be willing to undergo standard of care HIV testing and counseling

Who cannot take part

  • individuals who have received treatment for TB in the 60 days prior to enrolment
  • individuals who refuse informed consent
  • individuals who are unable to provide a sputum specimen for microbiological testing
  • individuals who have haemoptysis or a bloody cough with any forced coughs for audio recordings

This trial is currently available in South Africa.

Also in 1 other country, 1 site

  • Stellenbosch UniversityCape Town, South AfricaContact: Grant Theron, PhDTaking people

About the trial

What the trial wants to find out

TB is the single biggest infectious cause of death (1.5 million died in 2018), killing more HIV-positive people than any other disease, and is arguably the most important poverty-related disease in the world. TB's estimated incidence in Africa has been declining over recent years but progress is slow and plateauing. To avert stagnation, truly innovative and ambitious technologies are needed, especially those that improve case finding and time-to-diagnosis as, in mathematical models based on the TB care cascade framework, interventions that accomplish this will have the most impact on disrupting population-level transmission, including when deployed at facilities where patients are readily accessible. Critically, these interventions (triage tests) must promote access to confirmatory testing (e.g., Xpert MTB/RIF Ultra) by enabling patients to be referred rapidly and efficiently during the same visit. The investigators will optimise and evaluate a technology that, aside from the investigators early case-controlled study to show feasibility, is hitherto not meaningfully investigated for TB. This gap is alarming given, on one hand, the enormity of the TB epidemic and the need for a triage test and, on the other hand, promising proofs-of-concept that demonstrate high diagnostic accuracy of cough audio classifier for respiratory diseases such as pneumonia, asthma. pertussis, croup, and COPD. In some cases, these classification systems are CE-marked, awaiting FDA-approval, and subject to late-stage clinical trials. This demonstrates the promise of the underlying technological principle. CAGE-TB's innovation is further enhanced by: applying advanced machine learning methods that the team have specifically developed for TB patient cough audio analysis, use of mixed methods research - drawing from health economics, implementation science, and medical anthropology - to inform product design and assess barriers and facilitators to implementation, and uniquely for a TB diagnostic test, its potential deployment as a pure mHealth (smartphone-based) innovation that mitigates many barriers that typically jeopardise TPP criteria fulfilment.

The 2 groups in the trial

  • Discovery Cohort

    An anticipated number of 473 participants will be recruited in Cape Town, South Africa. Data (cough audio) will be collected and used to train a machine learning algorithm. The cough audio signal specific for TB will be refined. During the discovery phase, the ground truth obtained through biological testing of sputum specimens will be used to inform the machine learning.

    Treatment: Cough sounds

  • Validation Cohort

    In the validation phase, the cough audio signature will have its sensitivity and specificity measured in new patients in Cape Town, South Africa (n=511) and Kampala, Uganda (n=767). The data will be used to evaluate the performance of the algorithm.

    Treatment: Cough sounds

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Automated Smartphone-based Cough Audio Classification for Rapid Tuberculosis Triage Testing (Cough Audio triaGE for TB; CAGE-TB)
Plain-language title
Smartphone Cough Recordings to Help Screen for TuberculosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
6 May 2026